Escient Pharmaceuticals rakes in $40 mln Series A
San Diego-based Escient Pharmaceutials, a newly launched biotech company, has closed $40 million in Series A funding. The investors were The Column Group, 5AM Ventures and Osage University Partners.
9 May 2018•4 mins read
